Vimarsana
Biggest News Aggregation in the World

Daniel Addison News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Daniel Addison. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Daniel Addison Today - Breaking & Trending Today

American College of Cardiology (ACC) Program Set for Cardiac Oncology Conference, "Advancing the Cardiovascular Care of the Oncology Patient" - Vimarsana News

American College of Cardiology (ACC) Program Set for Cardiac Oncology Conference, "Advancing the Cardiovascular Care of the Oncology Patient"

The American College of Cardiology’s Cardiac Oncology Conference, “Advancing the Cardiovascular Care of the Oncology Patient,” will be held at the Heart House in Washington, D.C., Feb. 9-11, 2024. The event is offered as an interdisciplinary and interspecialty course with a robust program providing clinicians and researchers with the tools needed to improve the cardiovascular (CV) health of cancer patients in everyday practice.

More than sixty arrests for drink and drug driving in Cumbria - Vimarsana News

More than sixty arrests for drink and drug driving in Cumbria

So far this month, Cumbria Constabulary's Roads Policing Unit has arrested more than 60 drivers on suspicion of driving under the influence of drink…

Theatre review: Love, Lust, Lost, Austral Picture Theatre - Vimarsana News

Theatre review: Love, Lust, Lost, Austral Picture Theatre

Love, Lust, Lost is an immersive theatre show that ensures a different viewing experience every night.

Statement Outlines Inequities in Cardio-Oncology Care, Research - Vimarsana News

Statement Outlines Inequities in Cardio-Oncology Care, Research

The American Heart Association has released a statement on inequities in cardio-oncology care and research.

AHA Statement Addresses Equity in Cardio-Oncology Care - Vimarsana News

AHA Statement Addresses Equity in Cardio-Oncology Care

The AHA urges action to address differing cardiotoxicity risks from new and emerging cancer therapies among women and underrepresented patient groups.